Counterfeit and substandard drugs: a public health problem for Costa Rica and the word
Đã lưu trong:
| Nhiều tác giả: | , , , , |
|---|---|
| Định dạng: | artículo original |
| Trạng thái: | Versión publicada |
| Ngày xuất bản: | 2021 |
| Miêu tả: | The counterfeiting of medicines affects all countries around the world regardless of their geographical location or their economic development. In Costa Rica, large quantities of medicines, and other health-related products, have been confiscated by authorities. This shows how problematic the situation is, and the existence of a market that demands these products. The aim of this study is review of the most important concepts related to counterfeit and substandard medicines. In addition, a review of the alerts issued by the Ministry of Health from January 2009 to December 2019, is presented. In Costa Rica, a total of 64 alerts have been published with relevant information regarding the presence or possible circulation of counterfeit drugs (n = 20) and products without a sanitary registry approved by the Costa Rican Ministry of Health (n = 44). As examples, we present details of the alerts issued for intramuscular vitamin B complex, ceftriaxone, and oral contraceptives. Within this society, many actors can play an important role in the prevention of counterfeiting medicines. The health authority must be accompanied by the pharmaceutical industry, police forces, health professionals and their representatives, and any organization that seeks the safety of the patient. This end user must also be empowered to understand its treatment and the safest ways for obtaining and rationally use medications. |
| Quốc gia: | Portal de Revistas UCR |
| Tổ chức giáo dục: | Universidad de Costa Rica |
| Repositorio: | Portal de Revistas UCR |
| Ngôn ngữ: | Español |
| OAI Identifier: | oai:portal.ucr.ac.cr:article/46616 |
| Truy cập trực tuyến: | https://revistas.ucr.ac.cr/index.php/medica/article/view/46616 |